Prostate-specific antigen (PSA) levels in men 60 to 70 years of age predict aggressive prostate cancer in the PLCO cancer screening trial: Implications for risk-stratified screening

Specific Antigen ◽

Aggressive Prostate Cancer ◽

Cancer Screening Trial ◽

PD30-01 PROSTATE-SPECIFIC ANTIGEN (PSA) LEVELS IN MEN 60 TO 70 YEARS OF AGE PREDICT AGGRESSIVE PROSTATE CANCER IN THE PLCO CANCER SCREENING TRIAL: IMPLICATIONS FOR RISK-STRATIFIED SCREENING

The Journal of Urology ◽

10.1097/01.ju.0000556133.28739.2a ◽

2019 ◽

Vol 201 (Supplement 4) ◽

Author(s):

Alexandra Berger* ◽

Garrick Aden-Buie ◽

Adam Kibel ◽

Lorelei Mucci ◽

Kathryn Penney ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Screening ◽

Specific Antigen ◽

Aggressive Prostate Cancer ◽

Cancer Screening Trial ◽

Variation of Prostate-specific Antigen Value in Men and Risk of High-grade Prostate Cancer: Analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Study

Urology ◽

10.1016/j.urology.2015.02.013 ◽

2015 ◽

Vol 85 (5) ◽

pp. 1117-1122 ◽

Cited By ~ 2

Author(s):

Mathieu Boniol ◽

Philippe Autier ◽

Paul Perrin ◽

Peter Boyle

Keyword(s):

Prostate Cancer ◽

Ovarian Cancer ◽

Cancer Screening ◽

Specific Antigen ◽

High Grade ◽

Cancer Screening Trial ◽

Opportunistic Testing Versus Organized Prostate-specific Antigen Screening: Outcome After 18 Years in the Göteborg Randomized Population-based Prostate Cancer Screening Trial

European Urology ◽

10.1016/j.eururo.2014.12.006 ◽

2015 ◽

Vol 68 (3) ◽

pp. 354-360 ◽

Cited By ~ 57

Author(s):

Rebecka Arnsrud Godtman ◽

Erik Holmberg ◽

Hans Lilja ◽

Johan Stranne ◽

Jonas Hugosson

Keyword(s):

Prostate Cancer ◽

Cancer Screening ◽

Specific Antigen ◽

Population Based ◽

Prostate Specific Antigen Screening ◽

Cancer Screening Trial ◽

Test sensitivity of prostate-specific antigen in the Finnish randomised prostate cancer screening trial

International Journal of Cancer ◽

10.1002/ijc.20352 ◽

2004 ◽

Vol 111 (6) ◽

pp. 940-943 ◽

Cited By ~ 18

Author(s):

Anssi Auvinen ◽

Liisa Määttänen ◽

Patrik Finne ◽

Ulf-Håkan Stenman ◽

Jussi Aro ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Screening ◽

Specific Antigen ◽

Test Sensitivity ◽

Cancer Screening Trial ◽

Specificity of serum prostate-specific antigen determination in the Finnish prostate cancer screening trial

British Journal of Cancer ◽

10.1038/sj.bjc.6603522 ◽

2007 ◽

Vol 96 (1) ◽

pp. 56-60 ◽

Cited By ~ 15

Author(s):

L Määttänen ◽

M Hakama ◽

T L J Tammela ◽

M Ruutu ◽

M Ala-Opas ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Screening ◽

Specific Antigen ◽

Serum Prostate Specific Antigen ◽

Cancer Screening Trial ◽

Antigen Determination ◽

Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial

BJU International ◽

10.1111/bju.12153 ◽

2013 ◽

Vol 112 (6) ◽

pp. 735-741 ◽

Cited By ~ 46

Author(s):

Tytti H. Yli-Hemminki ◽

Marita Laurila ◽

Anssi Auvinen ◽

Liisa Määttänen ◽

Heini Huhtala ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Screening ◽

Specific Antigen ◽

Elevated Serum ◽

Serum Prostate Specific Antigen ◽

Cancer Screening Trial ◽

Re: Histological Inflammation and Risk of Subsequent Prostate Cancer among Men with Initially Elevated Serum Prostate-Specific Antigen (PSA) Concentration in the Finnish Prostate Cancer Screening Trial

The Journal of Urology ◽

10.1016/j.juro.2014.03.028 ◽

2014 ◽

Vol 191 (6) ◽

pp. 1808-1809

Author(s):

Edward M. Schaeffer

Keyword(s):

Prostate Cancer ◽

Cancer Screening ◽

Specific Antigen ◽

Elevated Serum ◽

Serum Prostate Specific Antigen ◽

Cancer Screening Trial ◽

Abstract 2201: Prostate-specific antigen velocity is associated with future prostate cancer mortality among men in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

10.1158/1538-7445.am2018-2201 ◽

2018 ◽

Author(s):

Erik Barr ◽

Sonja I. Berndt ◽

John D. Sorkin ◽

Wen-Yi Huang ◽

Kathryn Hughes Barry

Keyword(s):

Prostate Cancer ◽

Ovarian Cancer ◽

Cancer Screening ◽

Cancer Mortality ◽

Specific Antigen ◽

Prostate Cancer Mortality ◽

Cancer Screening Trial ◽

Positive biopsy (bx) rates for prostate cancer (PCA) based on prostate specific antigen (PSA) grouping in a large cancer screening trial: Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.4563 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 4563-4563

Author(s):

D. Reding ◽

C. McCarty ◽

T. Riley ◽

T. Hickey ◽

W. G. Hocking

Keyword(s):

Prostate Cancer ◽

Ovarian Cancer ◽

Cancer Screening ◽

Specific Antigen ◽

Positive Biopsy ◽

Cancer Screening Trial ◽

Prostate Specific Antigen Changes as Related to the Initial Prostate Specific Antigen: Data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70102-0 ◽

2007 ◽

Vol 2007 ◽

pp. 153-154

Author(s):

P.J. Loehrer

Keyword(s):

Ovarian Cancer ◽

Cancer Screening ◽

Specific Antigen ◽

Cancer Screening Trial ◽